SK Bioscience Co Ltd (302440) — Financial Flexibility Index
SK Bioscience Co Ltd (302440) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of ₩91.59 Billion (operating CF ₩20.65 Billion minus capex ₩70.94 Billion) represents 0% of total liabilities (₩847.96 Billion). Also explore how fast is SK Bioscience Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SK Bioscience Co Ltd Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for SK Bioscience Co Ltd across 7 annual periods. Check SK Bioscience Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for SK Bioscience Co Ltd (2018–2024)
Year-by-year free cash flow to debt coverage for SK Bioscience Co Ltd. For the full company profile including market capitalisation, see market cap of SK Bioscience Co Ltd.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.05x | ₩44.20 Billion | ₩-128.02 Billion | ₩821.14 Billion | ▼ -90.0% |
| 2023 | 0.54x | ₩79.64 Billion | ₩29.35 Billion | ₩148.58 Billion | ▲ +542.6% |
| 2022 | -0.12x | ₩-48.47 Billion | ₩-124.96 Billion | ₩400.23 Billion | ▼ -110.6% |
| 2021 | 1.14x | ₩579.50 Billion | ₩536.59 Billion | ₩508.81 Billion | ▲ +161.2% |
| 2020 | 0.44x | ₩130.15 Billion | ₩120.22 Billion | ₩298.44 Billion | ▲ +63.1% |
| 2019 | 0.27x | ₩45.79 Billion | ₩21.82 Billion | ₩171.25 Billion | ▲ +142.0% |
| 2018 | 0.11x | ₩21.21 Billion | ₩14.90 Billion | ₩191.98 Billion | — |